ABSTRACT
INTRODUCTION
In two other papers published in this issue, we reported subgroup analyses of the MERIDIAN study relating to the investigation of fetuses with apparent isolated ventriculomegaly 1 and isolated abnormalities of the corpus callosum (failed commisuration) 2 detected on antenatal ultrasound. In both studies we concluded that fetal magnetic resonance imaging (MRI) is a powerful adjunct to ultrasound and improves diagnostic accuracy and diagnostic confidence having a positive clinical impact in a high proportion of cases. Here we report the third subgroup analysis conducted in this fashion, which concerns the antenatal ultrasound detection of brain abnormalities apparently confined to the posterior fossa. This includes abnormalities of the cerebellum, brainstem and associated cerebrospinal fluid (CSF)-containing spaces.
This subgroup is different from the previous two, inasmuch as the fetal medicine focus groups that recommended this subgroup analysis recognized that it was likely that the diagnostic performance of ultrasound would be worse compared with MRI. This is in contrast to the subgroups with isolated ventriculomegaly and corpus callosum abnormalities in which the focus groups predicted (incorrectly) that most cases would be diagnosed accurately by ultrasound.
This paper reports the diagnostic accuracy and confidence of ultrasound and MRI for detecting posterior fossa abnormalities and, like the other two studies, assesses changes in prognostic information and clinical management of pregnant women brought about by including fetal MRI in the diagnostic pathway.
METHODS
The cases reported in this paper were recruited into the MERIDIAN study, the overarching methodology of which is reported elsewhere 3 , but the parts relevant to this paper are summarized here. Recruitment was conducted from 16 fetal medicine units in the UK and inclusion criteria for the main study were pregnant women aged 16 years or over carrying a fetus with brain abnormality detected by ultrasound at a gestational age of 18 weeks or more, who had no contraindication to MRI and who were willing to provide written, fully informed consent to enter the study. This subgroup analysis describes those fetuses with abnormalities confined to the posterior fossa (with or without associated ventriculomegaly), specifically those involving the brainstem or cerebellum (parenchymal abnormalities) and those involving CSF-containing lesions. Examples of parenchymal lesions include Dandy-Walker spectrum malformations, Chiari II malformation and cerebellar hypoplasia, whilst CSF-containing lesions include enlarged cisterna magna (CM), Blake's pouch cyst and arachnoid cysts.
Antenatal imaging with ultrasound and fetal MRI
The ultrasound studies were performed by appropriately trained NHS fetal medicine consultants and, after consent was obtained, each brain abnormality was listed using nomenclature from the ViewPoint antenatal ultrasound reporting software (GE Healthcare, Chalfont St Giles, UK) along with an assessment of certainty of diagnosis for each brain abnormality using a five-point Likert scale 4 . Subsequently, the women had an MRI examination performed on a 1.5-T superconducting clinical MRI system at one of six centers. The base requirement for the MRI assessment was to obtain T2-weighted images of the fetal brain in the three orthogonal planes and a T1-weighted ultrafast sequence in at least one plane (usually axial). The reporting radiologist was aware of the diagnoses and the level of certainty made on ultrasound from the study paperwork and also had access to the full clinical ultrasound report. The radiologist was required to comment on each brain abnormality recognized on ultrasound (using 'diagnosis excluded' if the finding was not present on MRI) and add extra anatomical diagnoses where appropriate onto a similar form as used for ultrasound. Each entry was accompanied by an indicator of confidence using the same Likert scale as for the ultrasound assessment.
Outcome reference data and assessment of diagnostic accuracy
In cases in which pregnancy continued and the child survived, outcome reference data (ORD) were obtained from the clinical notes based on diagnoses made on postnatal neuroimaging studies up to the age of 6 months. In cases of termination of pregnancy (TOP), stillbirth or neonatal death, the ORD were based on autopsy and/or postmortem MRI. An independent pediatric neuroradiologist determined whether a full review of ORD by a multidisciplinary independent expert panel was required. Full review was required unless there was complete and unequivocal agreement between the anatomical findings on ultrasound, MRI and the ORD. The multidisciplinary independent expert panel consisted of three NHS consultants (a neuroradiologist, fetal medicine consultant and pediatric neurologist) from a center that did not recruit into the MERIDIAN study and they were asked to judge whether the ultrasound-based and MRI-based diagnoses had complete agreement with the ORD. The primary analysis in the MERIDIAN study centered on participants who underwent MRI within 14 days of ultrasound and for whom ORD were available, and consisted of a calculation of diagnostic accuracy for ultrasound and MRI studies defined as: (true positives + true negatives)/total number of cases. Diagnostic accuracy was calculated for ultrasound and MRI and compared with ORD using McNemar's test.
Assessment of diagnostic confidence
In line with the main MERIDIAN study, the first analysis of diagnostic confidence simply describes the proportion of ultrasound and MRI diagnoses made with high and low confidence that were either correct or incorrect. 'High confidence' diagnoses were defined as 70% or 90% certainty and low confidence diagnoses were 10%, 30% or 50% certainty for the purposes of this analysis.
Our previous publication 5 describes the significant limitations of the conventional assessments of diagnostic confidence, even if the Omary correction 6 is used. The major limitation occurs because those methods do not require confirmation that the diagnoses are either correct or incorrect (i.e. no ORD are required). All cases in this study have ORD and we have chosen to use the 'score-based weighted average' method described by Ng and Palmer 7 as our preferred method of describing 'appropriate' diagnostic confidence. This approach uses not only diagnostic confidence assessments but also indicators of diagnostic accuracy as provided by the multidisciplinary independent expert panel, specifically the following: was the overall diagnosis correct for MRI? Was the overall diagnosis correct for ultrasound? Which imaging method described the most severe pathology? This aspect was combined with a binary assessment of diagnostic confidence as either 'high' or 'low' as described above. An algorithm modified from Ng and Palmer 7 ( Figure S1 ) was used to define a route label for each case and hence derive a route score ranging from −4 to +4. A value of zero indicated that there was no change in 'appropriate' confidence, positive values indicate a benefit from the inclusion of MRI in the diagnostic process and negative values indicate that MRI had a detrimental effect on appropriate diagnostic confidence, the larger the value the greater the effect. The mean, standard deviation and 95% CI were calculated and one sample t-tests were carried out to determine if the calculated scores differed from zero.
Assessment of effects on prognosis and clinical management
The MERIDIAN study collected data from the fetal medicine specialists about any changes in clinical management brought about by MRI, as described in detail elsewhere 3 ; in short, the specialists were asked to report whether MRI provided additional diagnostic information and whether it led to a change in the prognosis or management (including offering TOP) of the case.
With respect to analysis of prognostic information, the fetal medicine subspecialists were asked to report the prognostic information given to the woman based on the ultrasound scan (but before MRI) using the following five categories: normal (no worse than the risk to a fetus without a demonstrable brain abnormality), favorable (normal neurological outcome expected in > 90% of cases), intermediate (normal neurological outcome expected in 50-90% of cases), poor (normal neurological outcome expected in < 50% of cases) and unknown.
At the next consultation with the woman, at which time the MRI report was available, the clinician recorded the updated prognostic information using the same five categories. For the purposes of description in this report we describe if the prognosis remained the same, worsened or improved after MRI. This approach was straightforward when the prognosis was normal, favorable, intermediate or poor, and if the prognosis was unknown on both ultrasound and MRI. However, the decision was complicated when the prognosis on one imaging method was unknown but was specified on the other. In such cases we made the following assignations:
• ultrasound prognosis 'Unknown', MRI prognosis 'Normal' or 'Favorable' = improved prognosis
• ultrasound prognosis 'Unknown', MRI prognosis 'Intermediate' = no change in prognosis • ultrasound prognosis 'Unknown', MRI prognosis 'Poor' = worse prognosis • ultrasound prognosis 'Normal' or 'Favorable', MRI prognosis 'Unknown' = worse prognosis • ultrasound prognosis 'Intermediate', MRI prognosis 'Unknown' = no change in prognosis • ultrasound prognosis 'Poor', MRI prognosis 'Unknown' = no change in prognosis
If TOP was offered, clinicians were asked to report whether abnormalities seen on ultrasound only were sufficient to consider that option under Ground E of the Abortion Act 1967 (section 1(1)(d), 'substantial risk of serious mental or physical handicap') 8 and whether this decision was still valid after the MRI information was available.
RESULTS
Intracranial abnormalities confined to the posterior fossa were diagnosed on ultrasound in 81/570 (14.2%) fetuses from the MERIDIAN cohort. Out of these, 57 (70.4%) fetuses had the MRI study between 18 and 23 weeks and 24 (29.6%) at ≥ 24 weeks' gestational age. A parenchymal abnormality confined to the posterior fossa was diagnosed on ultrasound in 67/81 fetuses and a CSF-containing abnormality in 14/81. Associated ventriculomegaly was found on ultrasound in 25/81 (31%) cases overall and was present in 20% of the fetuses with cerebellar hypoplasia, 29% with Dandy-Walker spectrum abnormalities and 52% of fetuses with Chiari II malformation.
Diagnostic accuracy
The diagnostic accuracy data for the subgroup of fetuses with posterior fossa abnormalities are shown in Table 1 . The label 'any' abnormality of the posterior fossa does not distinguish between the type of posterior fossa abnormality, and therefore incorrect diagnoses occurred either when the ORD was normal or if a brain abnormality outside the posterior fossa was confirmed on ORD. Using that definition, ultrasound had an overall diagnostic accuracy of 65.4% and the 28 diagnostic errors in that group are described in Table 2 . ORD reported a normal brain in 18/28 of the ultrasound errors and other supratentorial brain abnormalities in 10/28 of the ultrasound errors (agenesis or hypogenesis of the corpus callosum (n = 6), cortical formation abnormality (n = 2), acquired pathology (n = 2)). MRI analysis of those cases gave a diagnostic accuracy of 87.7%, demonstrating an improvement in diagnostic accuracy of 22.3% (95% CI, 14.0-30.5%; P < 0.0001) over ultrasound. The 10 errors made on MRI consisted of eight cases in which the ORD were normal and two cases in which MRI failed to detect an abnormality of the corpus callosum shown on ORD. Example cases of agreements and disagreements are shown in Figures 1 and S2-S4 . The subgroup 'any' abnormality of the posterior fossa allows any diagnosis of isolated posterior fossa abnormality to be correct when compared with ORD, whereas subgroups 'parenchymal' and 'CSF' require more restrictive diagnoses (described in text) to be correct. *95% CIs calculated using exact conditional method due to small numbers within groups. †McNemar's test between ultrasound and MRI correct diagnoses. 
Parenchymal abnormalities
In 67/81 (83%) of the ultrasound-based diagnoses, a 'parenchymal abnormality' of the posterior fossa was described and the specific diagnoses on ultrasound included cerebellar hypoplasia in 25/67 (37%) cases (vermian hypoplasia (n = 15), hypoplasia of the cerebellar hemispheres (n = 10)), Dandy-Walker spectrum abnormalities in 21/67 (31%) and Chiari II malformation in 21/67 (31%). The label 'parenchymal abnormality' in Table 1 requires the exact pathological diagnosis of the posterior fossa abnormality to be correct when compared with ORD and ignores the presence or absence of other brain abnormalities. As such, ultrasound made the correct specific anatomical diagnosis in 54/67 fetuses (diagnostic accuracy 80.6%) and MRI provided the correct diagnosis in 64/67 fetuses (diagnostic accuracy 95.5%). The difference in diagnostic accuracy was 14.9% (95% CI, 5.7-24.1%; P = 0.002) in favor of MRI.
CSF-containing abnormalities
Of the 81 diagnoses made on ultrasound, 14 involved a 'CSF-containing abnormality', which consisted of eight fetuses with an enlarged CM and six fetuses with abnormal cystic structures (arachnoid cysts (n = 4), unspecified (n = 2)). Three of these 14 cases with an ultrasound diagnosis of a 'CSF abnormality' were correct when compared with ORD (diagnostic accuracy 21.4%). The ORD diagnoses in the 11/14 cases of incorrect diagnoses on ultrasound consisted of 'no brain abnormality' in eight fetuses, failed commissuration in two cases and durovenous thrombosis with ectasia 9 in one case ( Figure 2) . The MRI studies in those 14 fetuses provided the correct diagnosis in 8/14 cases (diagnostic accuracy 57.1%) with a difference in favor of MRI of 35.7% (95% CI, −1.6 to 73.0%, P = 0.0625). All of the errors on MRI were cases in which a CSF-containing abnormality was diagnosed but not confirmed on ORD, although a corpus callosum abnormality was also missed in one case. Figure 3 presents the proportions of correct and incorrect diagnoses made with high and low diagnostic confidence. High confidence diagnoses were made in 85% of fetuses on ultrasound and in 91% of fetuses on MRI, an increase of 6%. In 17/81 cases (21% of the entire subgroup) a high confidence diagnosis was made on ultrasound that was found to be incorrect on ORD, in comparison with 6/81 (7%) with high confidence but incorrect diagnosis made on MRI, indicating a 3-fold reduction. With respect to low confidence diagnoses, 5/81 (6%) were correct on ultrasound, whilst 4/81 (5%) were correct on MRI.
Diagnostic confidence
Diagnostic accuracy data were used in conjunction with diagnostic confidence data in order to calculate a 'score-based weighted average' value for each case, as shown in Figure 4 . In 49/81 cases (60%) the score was 0 indicating that MRI had no effect on diagnostic confidence in those cases, whilst the score was negative in 8/81 cases (10%) indicating a deleterious effect of MRI on 'appropriate' diagnostic confidence (Figure 4) . In 24/81 cases (30%) the score was positive indicating an 'appropriate' improvement in diagnostic performance. Formal analysis of the score-based weighted average graph showed a mean difference of +0.70 (95% CI +0.36 to +1.05, P < 0.0001) indicating an improvement in 'appropriate' diagnostic performance after inclusion of MRI in the diagnostic pathway.
Prognosis and clinical management
There were incomplete prognostic/clinical management data in 3/81 cases, all from the 'parenchymal abnormality' group. In the 78 cases in which complete prognostic/management data were available, fetal-maternal consultants reported that MRI provided additional diagnostic information in 38/78 (49%) fetuses compared with ultrasound. This included 5/14 (36%) from the 'CSF abnormality' group and 33/64 (52%) from Figure 3 High (rated as 70% or 90%) and low (rated as 10%, 30% or 50%) confidence diagnoses made on ultrasound (US) and magnetic resonance imaging (MRI). Shaded parts of bars indicate number of diagnoses that were incorrect, and unshaded parts indicate those that were correct, in comparison with outcome reference data.
the 'parenchymal abnormality' group. The prognostic information given to women after MRI changed in 34/78 (44%) cases. In 20 fetuses, the prognosis was worse after MRI, including 13 cases in which the prognosis became 'Poor'. In the 14 cases in which the prognosis improved Change in diagnostic confidence using route score method for posterior fossa cases (n = 81). There was a significant increase (0.7, P < 0.0001) in favor of positive scores.
after MRI, the prognosis was described as 'Normal' in three and 'Favorable' in six fetuses. TOP was offered to 33/78 (42%) women on the basis of the ultrasound findings alone (all from the 'parenchymal abnormality' group) and this increased to 45/78 (58%) after MRI (44 in the 'parenchymal abnormality' group). In 28 cases, TOP was offered both before and after MRI and in five cases the offer of TOP was reversed on the basis of the MRI findings. TOP was offered on the basis of the MRI findings alone in 17 cases. Hence, fundamental changes in the decision to offer TOP occurred in 22/78 cases (28%) and termination was performed in 16/78 (21%) cases. The effect of MRI on the final choice of clinical management was considered to be of no influence in eight out of the 78 cases, minor in 43, significant in 16, major in nine and decisive in two.
DISCUSSION
In this paper we present one of three subgroup analyses from the MERIDIAN cohort, all of which were defined by the type of anatomical abnormality described on antenatal ultrasound. The subgroups were suggested by expert focus groups and consisted of the three commonest fetal neuropathologies encountered during antenatal ultrasound: ventriculomegaly, failed commissuration and posterior fossa abnormalities. The subject of this report, posterior fossa abnormalities, differs from those of the two previous reports, mainly with respect to the composition of this subgroup. Ventriculomegaly is a single specific diagnosis relating to the size of the lateral ventricles (although it can result from a multitude of causes) and failed commissuration refers to varying degrees of underdevelopment of a single structure, the corpus callosum. In contrast, posterior fossa abnormalities form a heterogeneous group with a range of different pathologies some of which are likely to be conspicuous on imaging, and hence easy to detect, whilst others are more subtle. For example, Chiari II malformation was detected accurately on ultrasound and MRI in all cases. However, despite this, the expert focus groups believed that the diagnosis of posterior fossa abnormalities is difficult on ultrasound and that MRI was likely to have a larger positive effect on diagnostic accuracy and confidence when compared with diagnosis of fetuses with ventriculomegaly or failed commissuration.
The overall improvement in diagnostic accuracy of MRI over ultrasound shown in this study was based on an approximately 22% increase, double the rate of additional brain abnormalities being found in fetuses in the isolated ventriculomegaly subgroup (10%) 1 . In contrast, the improvement in diagnostic accuracy for detecting posterior fossa abnormalities was substantially lower than the improvement in cases of failed commissuration, in which MRI improved diagnostic accuracy from 34% to 95%. There was also a much clearer improvement in diagnostic confidence using MRI in the failed commissuration group compared with the subgroup with posterior fossa abnormalities, although the latter still showed a statistically significant improvement over ultrasound. The comparative diagnostic performance of ultrasound and MRI was closest for parenchymal abnormalities for which ultrasound had a diagnostic accuracy of 81% (when the nature of the posterior fossa pathology alone was considered) compared with 96% for MRI, although the difference still indicates an improvement for MRI. One important confounding factor to consider when interpreting these data concerns the cases of Chiari II malformation. Those are posterior fossa parenchymal abnormalities and, hence, were eligible for recruitment into the MERIDIAN study, but there is an invariable association between Chiari II malformation and open spinal dysraphism. The spinal pathology is often gross and easily detected on ultrasound and could potentially bias the results by 'signposting' the presence of the Chiari II malformation that would otherwise have been overlooked on antenatal ultrasound. There were 21 cases of Chiari II malformation in our subgroup and in all of those fetuses the ultrasound, MRI and ORD were all in agreement. If the fetuses with Chiari II malformation are excluded from analysis, the diagnostic accuracy for ultrasound in detecting parenchymal abnormalities becomes 72% (33/46 correct) and for MRI 93% (43/46 correct).
Although there were few (n = 14) fetuses with CSF-containing abnormalities in our subgroup, the diagnostic performance for both ultrasound and MRI in attempting to define CSF-containing abnormalities was worryingly poor (diagnostic accuracy for ultrasound 21%, diagnostic accuracy for MRI 57%). This is the only diagnostic accuracy analysis of the MERIDIAN data performed to date that has failed to show a statistically significant improvement of MRI over ultrasound (P = 0.0625), although this subgroup comprised only 14 fetuses. The commonest error category in this group was a normal ORD report but both imaging modalities reporting an enlarged CM. It is interesting to speculate why the performance of both ultrasound and MRI was poor for this particular type of pathology as there are no recognized specific technical or anatomical reasons to explain the suboptimal performance. One possibility is that the antenatal ultrasound and MRI examinations were correct at the time of the imaging studies in that enlarged CM is a temporary, but normal, feature in some fetuses that regresses and is no longer present in the neonate or infant 10 . Differential growth of the cerebellum/bony posterior fossa and postnatal changes in CSF resorption are possible mechanisms to explain this supposition. Another possibility is that the ORD were wrong and the reported enlarged CMs were indeed abnormal and could be explained by the mechanism by which ORD were collected in this study. It was not possible to insist on postnatal MRI examinations in this study; rather, we had to rely on the neuroimaging that had been performed for clinical purposes up to the age of 6 months. It is highly likely that most babies with enlarged CM as the only intracranial finding will have no evidence of neurodevelopmental problems and therefore postnatal MRI examinations are unlikely to be requested. As a result, the only postnatal imaging will be transfontanelle cranial ultrasonography, which is known to be poor at showing the posterior fossa 11, 12 , particularly the extra-axial spaces. As such, an enlarged CM could be missed. Both of the suggestions to explain the poor performance of ultrasound and MRI can be easily examined and future imaging studies could be designed to answer this question and the results will be important in terms of counseling given to a woman whose fetus has an enlarged CM.
Even in the present form, however, the results of MRI had a substantial impact on prognosis and clinical management in cases of fetal posterior fossa abnormalities. The prognostic category changed in 44% of cases after MRI and in slightly more than half of those cases the prognosis worsened. The overall effect of MRI was an increase in the rate at which TOP was offered to women, approximately 42% on the basis of the ultrasound findings alone to approximately 58% after MRI. In five women, the offer of TOP made on the basis of ultrasound alone was reversed after MRI, so the individual rate of change with respect to offer of TOP was 17/78 (approximately 22%). The effects on clinical management were considered to be significant, major or decisive in 35% of pregnancies.
The challenges of achieving the correct anatomical diagnosis of posterior fossa abnormalities using ultrasound, predicted by the expert focus groups, were realized, as was the improvement brought about by supplementing the ultrasound examination with MRI. The improvement in diagnostic accuracy and confidence arising from performing MRI studies was accompanied by changes of prognosis and clinical management in approximately 40% of cases. We conclude, therefore, that MRI be offered routinely to women whose fetus has a posterior fossa abnormality detected on antenatal ultrasound.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Figure S1 Algorithm used to provide score-based weighted average data to assess changes in appropriate confidence (modified from Ng and Palmer 7 ). IU-MR, in-utero magnetic resonance. 
Figure S4
A case of disagreement between ultrasound and outcome reference data with correct diagnosis made on fetal magnetic resonance imaging (MRI). This fetus was the result of a dizygotic twin pregnancy and was recruited into the MERIDIAN study on the basis of cerebellar hypoplasia on ultrasound. The other twin was normal. MRI was performed at 25 weeks' gestational age and confirmed a small (in terms of transcerebellar diameter) cerebellum (a) but also showed lack of indentation at the site of the normal cerebellar vermis (arrow in (a)). The inferior-superior vermian height appears to be normal (b) but there is none of the normal morphology of the cerebellar vermis. This indicates non-formation of the vermis and abnormal continuity of the cerebellar hemispheres over the mid-line, i.e. rhombencephalosynapsis. These features were confirmed on postnatal imaging (c,d).
